Oral sirolimus with BMS may reduce in-stent restenosis Healio A short-term regimen of oral sirolimus after bare-metal stent implantation yielded significant reductions of in-stent restenosis and target lesion revascularization, according to recent findings. Additionally, the rates of in-stent restenosis were ... |
